Chromocell Therapeutics C...

2.68
-0.02 (-0.74%)
At close: Jan 23, 2025, 3:59 PM
2.86
6.70%
After-hours Jan 23, 2025, 07:38 PM EST

Ratios (Annual)

Discover comprehensive ratio statement breakdowns that reveal insights into revenue, expenses, and beyond.
Year FY23 FY22 FY21 FY20
PE Ratio -3.75 -11.26 -46.5 -41.91
PS Ratio n/a n/a n/a 138.47
PB Ratio -4.3 -7.47 -7.52 -7.74
P/FCF Ratio -28.22 -17.67 -17.38 -7.64
P/OCF Ratio -28.22 -17.67 -17.38 -7.64
OCF/S Ratio n/a n/a n/a -18.13
Debt / Equity Ratio -0.2 -0.15 -0.3 -0.07
Quick Ratio 0.01 0.01 n/a 0.02
Current Ratio 0.01 0.01 n/a 0.02
Asset Turnover n/a n/a n/a 2.78
Interest Coverage -13.23 -16.51 -3.32K -807.8
Return on Equity (ROE) 1.15 0.66 0.16 0.18
Return on Assets (ROA) -76.57 -44.64 n/a -9.19
Return on Capital (ROIC) 1.06 0.63 0.33 0.38
Dividend Yield n/a n/a n/a n/a
Payout Ratio n/a n/a n/a n/a
Gross Profit Margin n/a n/a n/a 30.68%
Net Profit Margin n/a n/a n/a -330.4%
Pretax Profit Margin n/a n/a n/a -330.4%
Operating Profit Margin n/a n/a n/a -677.16%
FCF Margin n/a n/a n/a -1.81K%
EBITDA Margin n/a n/a n/a n/a